ProMIS to showcase its Alzheimer\'s, Parkinson\'s and ALS programs at notable biotech investor events TORONTO and CAMBRIDGE, MA, Dec. 18, 2018 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]na-focusjpmweek-300767787.html